Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy.

ABSTRACT:

Importance

Stratifying patients with biochemical recurrence (BCR) after primary treatment for prostate cancer based on the risk of prostate cancer-specific mortality (PCSM) is essential for determining the need for further testing and treatments.

Objective

To evaluate the association of BCR after radical prostatectomy or radiotherapy and its current risk stratification with PCSM.

Design, setting, and participants

This population-based cohort study included a total of 16 311 male patients with 10 364 (64%) undergoing radical prostatectomy and 5947 (36%) undergoing radiotherapy with curative intent (cT1-3, cM0) and PSA follow-up in Stockholm, Sweden, between 2003 and 2019. Follow-up for all patients was until death, emigration, or end of the study (ie, December 31, 2018

SUBMITTER: Falagario UG 

PROVIDER: S-EPMC10495864 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature